Patient Research
Sign in
All studies
RecruitingPHASE2INTERVENTIONAL

Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus Challenge

At a glance

Status
Recruiting
Phase
PHASE2
Sponsor
Ethris GmbH
Enrolment target
50
Start
24 Jun 2025
Estimated completion
01 Jun 2026
Asthma (Diagnosis)

What is this study about?

A Phase IIa trial in participants with asthma to evaluate the impact of intranasal ETH47 on the development of asthma-related symptoms following rhinovirus challenge

Who may be eligible?

Age 18 Years to 65 Years · Sex: ALL

Locations (1)

  • Virtus Respiratory Research Ltd and Imperial College Healthcare NHS Trust
    London, United Kingdom· Recruiting

How to find out more

Dr. Philipp Schreppel

schreppel@ethris.com +4989244153042 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Phase IIa Trial in Participants With Asthma to Evaluate Impa…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.